AIM IMMUNOTECH INC. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations
AIM IMMUNOTECH INC. (AIM) had Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations of $9.90 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations · last filed 2026-08-07
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $9.90M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $5.82M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $2.98M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $2.35M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations |
|---|---|
| 2026-06-30 | $9.90M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $5.82M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $2.98M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $2.35M 10-Q · filed 2025-11-17 |
| 2025-06-30 | $476.00K 10-Q · filed 2026-08-07 |
| 2025-03-31 | $898.00K 10-Q · filed 2026-05-15 |
| 2024-12-31 | $1.70M 10-Q · filed 2026-08-07 |
| 2024-09-30 | $915.00K 10-Q · filed 2025-11-17 |
| 2024-06-30 | $3.55M 10-Q · filed 2025-08-14 |
| 2024-03-31 | $3.29M 10-Q · filed 2025-05-15 |
| 2023-12-31 | $5.44M 10-K · filed 2026-03-27 |
| 2023-09-30 | $15.26M 10-Q · filed 2024-11-14 |
| 2023-06-30 | $21.04M 10-Q · filed 2024-08-14 |
| 2023-03-31 | $23.39M 10-Q · filed 2024-05-15 |
| 2022-12-31 | $27.05M 10-K · filed 2025-03-27 |
| 2022-09-30 | $29.76M 10-Q · filed 2023-11-14 |
| 2022-06-30 | $34.45M 10-Q · filed 2023-08-14 |
| 2022-03-31 | $28.99M 10-Q · filed 2023-05-15 |
| 2021-12-31 | $32.09M 10-K · filed 2024-04-01 |
| 2021-09-30 | $37.35M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $41.14M 10-Q · filed 2022-08-15 |
| 2021-03-31 | $48.77M 10-Q · filed 2022-05-13 |
| 2020-12-31 | $38.50M 10-K · filed 2023-03-31 |
| 2020-09-30 | $38.50M 10-Q · filed 2021-11-15 |
| 2020-06-30 | $33.91M 10-Q · filed 2021-08-16 |
| 2020-03-31 | $27.59M 10-Q · filed 2021-05-17 |
| 2019-12-31 | $1.47M 10-K · filed 2022-03-31 |
| 2019-09-30 | $9.62M 10-Q · filed 2020-11-12 |
| 2019-06-30 | $959.00K 10-Q · filed 2020-08-14 |
| 2019-03-31 | $2.39M 10-Q · filed 2020-05-14 |
| 2018-12-31 | $299.00K 10-K · filed 2021-03-31 |
| 2018-09-30 | $4.05M 10-Q · filed 2019-11-14 |
| 2018-06-30 | $3.57M 10-Q · filed 2019-08-14 |
| 2017-12-31 | $1.41M 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |